CervoMed Reports Third Quarter Financial Results and Cash Runway Through Q3 2027
CervoMed (CRVO) has announced its financial results for the third quarter, reporting a net loss of approximately $5.9 million. As of September 30, 2026, the company held $19.6 million in cash, cash equivalents, and marketable securities, representing a slight decrease from the $20.9 million reported at the end of 2025. Despite the quarterly loss, management stated that current liquidity levels are sufficient to fund planned operating expenses and capital expenditures through the third quarter of 2027. This provides the clinical-stage company with a defined runway to continue its development activities over the next year.
Tickers: $CRVO
Topics: cash runway liquidity net loss quarterly earnings
Read the full article at Seeking Alpha
Part of the story CNA Financial Reports Third Quarter 2026 Net Income of $196 Million (16 articles)